Contemporary medical, device, and surgical therapies for obesity in adults

CM Perdomo, RV Cohen, P Sumithran, K Clément… - The Lancet, 2023 - thelancet.com
The goal of obesity management is to improve health. Sustained weight loss of more than
10% overall bodyweight improves many of the complications associated with obesity (eg …

[HTML][HTML] Role of endoscopic vacuum therapy in the management of gastrointestinal transmural defects

DTH de Moura, BFBH de Moura… - World Journal of …, 2019 - ncbi.nlm.nih.gov
A gastrointestinal (GI) transmural defect is defined as total rupture of the GI wall, and these
defects can be divided into three categories: perforations, leaks, and fistulas. Surgical …

Obesity management in Prader–Willi syndrome: Current perspectives

A Crinò, D Fintini, S Bocchini… - … , metabolic syndrome and …, 2018 - Taylor & Francis
Prader–Willi syndrome (PWS) is a complex multisystem disorder due to the absent
expression of the paternally active genes in the PWS critical region on chromosome 15 …

Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international …

A Sartoretto, Z Sui, C Hill, M Dunlap, AR Rivera… - Obesity Surgery, 2018 - Springer
Objective Endoscopic sleeve gastroplasty (ESG), an incisionless endoscopic bariatric
procedure, has shown impressive results in case series. This study examines the …

Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases

MG Neto, LB Silva, E Grecco, LG de Quadros… - Surgery for Obesity and …, 2018 - Elsevier
Abstract Background Intragastric balloons (IGBs) are a minimally invasive option for obesity
treatment, acting as a space-occupying device and leading to weight loss through increased …

Intragastric balloon treatment for obesity: review of recent studies

CM Tate, A Geliebter - Advances in therapy, 2017 - Springer
Introduction The FDA recently approved three intragastric balloon (IGB) devices, ReShape,
ORBERA™, and Obalon for treatment of obesity. Given the high cost, complication risk, and …

Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study

S Barrichello, DTH de Moura, EGH de Moura… - Gastrointestinal …, 2019 - Elsevier
Background and Aims Obesity is a pandemic affecting approximately 700 million adults
worldwide, with an additional 2 billion overweight. Endoscopic sleeve gastroplasty (ESG) is …

Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis

AA de Miranda Neto, DTH de Moura, IB Ribeiro… - Obesity surgery, 2020 - Springer
Background Endoscopic sleeve gastroplasty (ESG) has emerged as a promising technique
in endoscopic bariatric and metabolic therapies (EBMTs). We aimed to perform a systematic …

Endoscopic vacuum therapy (EVT) for the treatment of post-bariatric surgery leaks and fistulas: a systematic review and meta-analysis

JMV Intriago, DTH de Moura, ES do Monte Junior… - Obesity Surgery, 2022 - Springer
Bariatric surgery remains the most effective treatment for morbid obesity and its
comorbidities. However, post-surgical leaks and fistulas can occur in about 1–5% of …

[HTML][HTML] Six intragastric balloons: Which to choose?

G Stavrou, A Shrewsbury… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Endoscopically placed intragastric balloons (IGBs) have played a significant role in obesity
treatment over the last 30 years, successfully bridging the gap between lifestyle modification …